 |
|
A Review of the Association of Estrogens and Progestins With Cardiovascular Disease in Postmenopausal Women
Bruce M. Psaty, MD, PhD;
Susan R. Heckbert, MD, PhD;
David Atkins, MD, MPH;
David S. Siscovick, MD, MPH;
Thomas D. Koepsell, MD, MPH;
Patricia W. Wahl, PhD;
W. T. Longstreth, Jr, MD, MPH;
Noel S. Weiss, MD, DrPH;
Edward H. Wagner, MD, MPH;
Ross Prentice, PhD;
Curt D. Furberg, MD, PhD
Arch Intern Med. 1993;153(12):1421-1427.
Abstract
| |
The purpose of this article was to review, with special attention to the hypothesized mechanisms of atherosclerosis and thrombosis, the literature on the association of estrogens and progestins with cardiovascular disease. The data sources included recent reviews and their citations as well as literature searches of Medline. For coronary heart disease, we relied on a recent meta-analysis; for the lipid effects of estrogens and progestins, we refer to recent reviews and studies; for stroke, we identified all cohort and case-control studies; and for the effects of hormones on coagulation factors, we identified all relevant studies. The lipid effects of estrogens in postmenopausal women probably prevent atherosclerosis, and we would expect long duration of use rather than current use to provide the greatest benefit. Few epidemiologic studies have, however, assessed duration of estrogen use. High doses of estrogens are likely to be thrombogenic during current use, and it is possible that even moderate doses may increase the risk of clotting among women who smoke or who have existing coronary atherosclerosis. Compared with the lipid effects of estrogens alone, the lipid effects of combined therapy with progestins may increase atherosclerosis. The effect of progestins on coagulation factors is largely unknown, and no epidemiologic study has assessed the risk of cardiovascular disease associated with the use of combined hormone therapy in postmenopausal women. Cardiovascular risk or benefit associated with the use of postmenopausal hormones may involve several competing mechanisms, including effects on prostaglandins and vascular tone as well as atherosclerosis and thrombosis.
(Arch Intern Med. 1993;153:1421-1427)
Author Affiliations
From the Departments of Medicine (Drs Psaty, Atkins, Siscovick, Koepsell, and Longstreth), Epidemiology (Drs Psaty, Heckbert, Siscovick, Koepsell, and Weiss), Biostatistics (Drs Wahl and Prentice), and Health Services (Drs Psaty, Koepsell, and Wagner), University of Washington; Center for Health Studies, Group Health Cooperative of Puget Sound (Dr Wagner); Fred Hutchinson Cancer Research Center (Dr Prentice), Seattle; and Department of Public Health Sciences, Bowman Gray School of Medicine, Winston-Salem, NC (Dr Furberg).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction
Reiner et al.
Blood 2003;102:25-30.
ABSTRACT
| FULL TEXT
Effect of Estrogen Plus Progestin on Progression of Carotid Atherosclerosis in Postmenopausal Women With Heart Disease: HERS B-Mode Substudy
Byington et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:1692-1697.
ABSTRACT
| FULL TEXT
Hormone Replacement Therapy and Associated Risk of Stroke in Postmenopausal Women
Lemaitre et al.
Arch Intern Med 2002;162:1954-1960.
ABSTRACT
| FULL TEXT
Female Hormones and Thrombosis
Rosendaal et al.
Arterioscler. Thromb. Vasc. Bio. 2002;22:201-210.
ABSTRACT
| FULL TEXT
Hormone Replacement Therapy, Prothrombotic Mutations, and the Risk of Incident Nonfatal Myocardial Infarction in Postmenopausal Women
Psaty et al.
JAMA 2001;285:906-913.
ABSTRACT
| FULL TEXT
Effects of Continuous Estrogen and Estrogen-Progestin Replacement Regimens on Cardiovascular Risk Markers in Postmenopausal Women
Davidson et al.
Arch Intern Med 2000;160:3315-3325.
ABSTRACT
| FULL TEXT
Estriol (E3) Replacement Improves Endothelial Function and Bone Mineral Density in Very Elderly Women
Hayashi et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2000;55:183B-190.
ABSTRACT
| FULL TEXT
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation : Analysis of 2012 Participants in the SPAF I–III Clinical Trials
Hart et al.
Stroke 1999;30:1223-1229.
ABSTRACT
| FULL TEXT
Different prevalence of asymptomatic atherosclerotic lesions in males and females
Kroger et al.
Vasc Med 1999;4:61-65.
ABSTRACT
Ischemic Stroke and Use of Estrogen and Estrogen/Progestogen as Hormone Replacement Therapy
Petitti et al.
Stroke 1998;29:23-28.
ABSTRACT
| FULL TEXT
Effect of Estrogen on Very Low Density Lipoprotein and Low Density Lipoprotein Subclass Metabolism in Postmenopausal Women
Campos et al.
J. Clin. Endocrinol. Metab. 1997;82:3955-3963.
ABSTRACT
| FULL TEXT
Effects of Oral and Transdermal Estrogen/Progesterone Regimens on Blood Coagulation and Fibrinolysis in Postmenopausal Women : A Randomized Controlled Trial
Scarabin et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:3071-3078.
ABSTRACT
| FULL TEXT
Androgen Receptor-Mediated Antagonism of Estrogen-Dependent Low Density Lipoprotein Receptor Transcription in Cultured Hepatocytes
Croston et al.
Endocrinology 1997;138:3779-3786.
ABSTRACT
| FULL TEXT
Duration of Estrogen Replacement Therapy in Relation to the Risk of Incident Myocardial Infarction in Postmenopausal Women
Heckbert et al.
Arch Intern Med 1997;157:1330-1336.
ABSTRACT
A Comparison of Estrogen Replacement, Pravastatin, and Combined Treatment for the Management of Hypercholesterolemia in Postmenopausal Women
Davidson et al.
Arch Intern Med 1997;157:1186-1192.
ABSTRACT
Patient-Specific Decisions About Hormone Replacement Therapy in Postmenopausal Women
Col et al.
JAMA 1997;277:1140-1147.
ABSTRACT
Medroxyprogesterone Attenuates Estrogen-Mediated Inhibition of Neointima Formation After Balloon Injury of the Rat Carotid Artery
Levine et al.
Circulation 1996;94:2221-2227.
ABSTRACT
| FULL TEXT
No Association of Menopause and Hormone Replacement Therapy With Carotid Artery Intima-Media Thickness
Nabulsi et al.
Circulation 1996;94:1857-1863.
ABSTRACT
| FULL TEXT
Hormone replacement therapy may not always be right choice to prevent cardiovascular disease
Panico et al.
BMJ 1996;313:687-687.
FULL TEXT
Association of Hormone Replacement Therapy With Hemostatic and Other Cardiovascular Risk Factors : The FINRISK Hemostasis Study
Salomaa et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1549-1555.
ABSTRACT
| FULL TEXT
The Risk of Myocardial Infarction Associated With the Combined Use of Estrogens and Progestins in Postmenopausal Women
Psaty et al.
Arch Intern Med 1994;154:1333-1339.
ABSTRACT
Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer
Whitmore
JAMA 1994;271:1236-1236.
ABSTRACT
|
